Trial Profile
Phase II trial of MAP 4343 in acute neurotraumatic injuries
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Apr 2016
Price :
$35
*
At a glance
- Drugs Pregnenolone methyl ether (Primary)
- Indications Brain injuries; Spinal cord injuries
- Focus Therapeutic Use
- Sponsors Mapreg
- 25 Apr 2016 New trial record